CVS has agreed to pay $315 million to settle federal claims over how its pharmacies filled opioid prescriptions. The CVS opioid settlement, announced by the U.S. Department of Justice on Oct. 13, covers more than 12 years of controlled substance prescriptions. Prosecutors said some of those prescriptions paired opioids with other sedating drugs in dangerous combinations. However, CVS disputes the claims and did not admit wrongdoing, the Associated Press reports.
Still, the case raises a key question for patients: How do you know a controlled substance is safe for you? Below, medical experts explain what the settlement means, why some drug combinations are risky and how to protect yourself.
Why was CVS sued?
The Justice Department filed its complaint in December 2024 in federal court in Rhode Island, where CVS is based. The case began as a whistleblower lawsuit filed by Hillary Estright, a former CVS employee.
The government alleged that from October 2013 through December 2025, CVS pharmacies filled prescriptions that:
- Contained dangerous and excessive quantities of opioids.
- Were filled too early.
- Combined an opioid, a benzodiazepine and a muscle relaxant, a mix known as the “trinity.”
- Came from so-called pill mill prescribers who wrote prescriptions without a legitimate medical purpose.
The government also alleged that CVS billed Medicare and other federal health programs for many of those prescriptions. In addition, the complaint claimed that performance metrics, incentive pay and short staffing put profits ahead of patient safety. CVS policies also allegedly kept pharmacists from warning one another about problem prescribers.
CVS strongly disagrees with the claims, and the settlement includes no finding of liability. Notably, the CVS opioid settlement is separate from the roughly $5 billion deal CVS announced with state and local governments in 2022, as reported by CBS News.
Recent Comments